Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions</title><author><name sortKey="Turner, Jennifer J" sort="Turner, Jennifer J" uniqKey="Turner J" first="Jennifer J." last="Turner">Jennifer J. Turner</name><affiliation><nlm:aff id="aff1">Department of Histopathology, Douglass Hanly Moir Pathology, and the Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</nlm:aff></affiliation></author><author><name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M." last="Morton">Lindsay M. Morton</name><affiliation><nlm:aff id="aff2">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Linet, Martha S" sort="Linet, Martha S" uniqKey="Linet M" first="Martha S." last="Linet">Martha S. Linet</name><affiliation><nlm:aff id="aff2">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Clarke, Christina A" sort="Clarke, Christina A" uniqKey="Clarke C" first="Christina A." last="Clarke">Christina A. Clarke</name><affiliation><nlm:aff id="aff3">Cancer Prevention Institute of California, Fremont, CA;</nlm:aff></affiliation></author><author><name sortKey="Kadin, Marshall E" sort="Kadin, Marshall E" uniqKey="Kadin M" first="Marshall E." last="Kadin">Marshall E. Kadin</name><affiliation><nlm:aff id="aff4">Boston University School of Medicine, Department of Dermatology and Skin Surgery, Roger Williams Medical Center, Providence, RI;</nlm:aff></affiliation></author><author><name sortKey="Vajdic, Claire M" sort="Vajdic, Claire M" uniqKey="Vajdic C" first="Claire M." last="Vajdic">Claire M. Vajdic</name><affiliation><nlm:aff id="aff5">Prince of Wales Clinical School and Lowy Cancer Research Center, University of New South Wales, Australia;</nlm:aff></affiliation></author><author><name sortKey="Monnereau, Alain" sort="Monnereau, Alain" uniqKey="Monnereau A" first="Alain" last="Monnereau">Alain Monnereau</name><affiliation><nlm:aff id="aff6">Hematological Malignancies Registry of Gironde, Bergonie Institute, Bordeaux, France, and UMRS-1018 Environmental Epidemiology of Cancer, Inserm, Paris-Sud University, Paris, France;</nlm:aff></affiliation></author><author><name sortKey="Maynadie, Marc" sort="Maynadie, Marc" uniqKey="Maynadie M" first="Marc" last="Maynadié">Marc Maynadié</name><affiliation><nlm:aff id="aff7">Hematological Malignancies Registry of Côte d'Or, University of Burgundy, Dijon, France;</nlm:aff></affiliation></author><author><name sortKey="Chiu, Brian C H" sort="Chiu, Brian C H" uniqKey="Chiu B" first="Brian C.-H." last="Chiu">Brian C.-H. Chiu</name><affiliation><nlm:aff id="aff8">Department of Health Studies, University of Chicago, Chicago, IL;</nlm:aff></affiliation></author><author><name sortKey="Marcos Gragera, Rafael" sort="Marcos Gragera, Rafael" uniqKey="Marcos Gragera R" first="Rafael" last="Marcos-Gragera">Rafael Marcos-Gragera</name><affiliation><nlm:aff id="aff9">Epidemiology Unit, Cancer Registry of Girona, Oncology Planning, Department of Health, Institute of Biomedical Investigation, Girona, Spain;</nlm:aff></affiliation></author><author><name sortKey="Costantini, Adele Seniori" sort="Costantini, Adele Seniori" uniqKey="Costantini A" first="Adele Seniori" last="Costantini">Adele Seniori Costantini</name><affiliation><nlm:aff id="aff10">Cancer Research and Prevention Institute Epidemiology, Florence, Italy;</nlm:aff></affiliation></author><author><name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R." last="Cerhan">James R. Cerhan</name><affiliation><nlm:aff wicri:cut="; and" id="aff11">Division of Epidemiology, College of Medicine, Mayo Clinic, Rochester, MN</nlm:aff></affiliation></author><author><name sortKey="Weisenburger, Dennis D" sort="Weisenburger, Dennis D" uniqKey="Weisenburger D" first="Dennis D." last="Weisenburger">Dennis D. Weisenburger</name><affiliation><nlm:aff id="aff12">Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20699439</idno><idno type="pmc">2993636</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993636</idno><idno type="RBID">PMC:2993636</idno><idno type="doi">10.1182/blood-2010-06-289561</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">001789</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001789</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions</title><author><name sortKey="Turner, Jennifer J" sort="Turner, Jennifer J" uniqKey="Turner J" first="Jennifer J." last="Turner">Jennifer J. Turner</name><affiliation><nlm:aff id="aff1">Department of Histopathology, Douglass Hanly Moir Pathology, and the Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</nlm:aff></affiliation></author><author><name sortKey="Morton, Lindsay M" sort="Morton, Lindsay M" uniqKey="Morton L" first="Lindsay M." last="Morton">Lindsay M. Morton</name><affiliation><nlm:aff id="aff2">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Linet, Martha S" sort="Linet, Martha S" uniqKey="Linet M" first="Martha S." last="Linet">Martha S. Linet</name><affiliation><nlm:aff id="aff2">Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</nlm:aff></affiliation></author><author><name sortKey="Clarke, Christina A" sort="Clarke, Christina A" uniqKey="Clarke C" first="Christina A." last="Clarke">Christina A. Clarke</name><affiliation><nlm:aff id="aff3">Cancer Prevention Institute of California, Fremont, CA;</nlm:aff></affiliation></author><author><name sortKey="Kadin, Marshall E" sort="Kadin, Marshall E" uniqKey="Kadin M" first="Marshall E." last="Kadin">Marshall E. Kadin</name><affiliation><nlm:aff id="aff4">Boston University School of Medicine, Department of Dermatology and Skin Surgery, Roger Williams Medical Center, Providence, RI;</nlm:aff></affiliation></author><author><name sortKey="Vajdic, Claire M" sort="Vajdic, Claire M" uniqKey="Vajdic C" first="Claire M." last="Vajdic">Claire M. Vajdic</name><affiliation><nlm:aff id="aff5">Prince of Wales Clinical School and Lowy Cancer Research Center, University of New South Wales, Australia;</nlm:aff></affiliation></author><author><name sortKey="Monnereau, Alain" sort="Monnereau, Alain" uniqKey="Monnereau A" first="Alain" last="Monnereau">Alain Monnereau</name><affiliation><nlm:aff id="aff6">Hematological Malignancies Registry of Gironde, Bergonie Institute, Bordeaux, France, and UMRS-1018 Environmental Epidemiology of Cancer, Inserm, Paris-Sud University, Paris, France;</nlm:aff></affiliation></author><author><name sortKey="Maynadie, Marc" sort="Maynadie, Marc" uniqKey="Maynadie M" first="Marc" last="Maynadié">Marc Maynadié</name><affiliation><nlm:aff id="aff7">Hematological Malignancies Registry of Côte d'Or, University of Burgundy, Dijon, France;</nlm:aff></affiliation></author><author><name sortKey="Chiu, Brian C H" sort="Chiu, Brian C H" uniqKey="Chiu B" first="Brian C.-H." last="Chiu">Brian C.-H. Chiu</name><affiliation><nlm:aff id="aff8">Department of Health Studies, University of Chicago, Chicago, IL;</nlm:aff></affiliation></author><author><name sortKey="Marcos Gragera, Rafael" sort="Marcos Gragera, Rafael" uniqKey="Marcos Gragera R" first="Rafael" last="Marcos-Gragera">Rafael Marcos-Gragera</name><affiliation><nlm:aff id="aff9">Epidemiology Unit, Cancer Registry of Girona, Oncology Planning, Department of Health, Institute of Biomedical Investigation, Girona, Spain;</nlm:aff></affiliation></author><author><name sortKey="Costantini, Adele Seniori" sort="Costantini, Adele Seniori" uniqKey="Costantini A" first="Adele Seniori" last="Costantini">Adele Seniori Costantini</name><affiliation><nlm:aff id="aff10">Cancer Research and Prevention Institute Epidemiology, Florence, Italy;</nlm:aff></affiliation></author><author><name sortKey="Cerhan, James R" sort="Cerhan, James R" uniqKey="Cerhan J" first="James R." last="Cerhan">James R. Cerhan</name><affiliation><nlm:aff wicri:cut="; and" id="aff11">Division of Epidemiology, College of Medicine, Mayo Clinic, Rochester, MN</nlm:aff></affiliation></author><author><name sortKey="Weisenburger, Dennis D" sort="Weisenburger, Dennis D" uniqKey="Weisenburger D" first="Dennis D." last="Weisenburger">Dennis D. Weisenburger</name><affiliation><nlm:aff id="aff12">Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE</nlm:aff></affiliation></author></analytic><series><title level="j">Blood</title><idno type="ISSN">0006-4971</idno><idno type="eISSN">1528-0020</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>After publication of the updated World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues in 2008, the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) now presents an update of the hierarchical classification of lymphoid neoplasms for epidemiologic research based on the 2001 WHO classification, which we published in 2007. The updated hierarchical classification incorporates all of the major and provisional entities in the 2008 WHO classification, including newly defined entities based on age, site, certain infections, and molecular characteristics, as well as borderline categories, early and “in situ” lesions, disorders with limited capacity for clinical progression, lesions without current International Classification of Diseases for Oncology, 3rd Edition codes, and immunodeficiency-associated lymphoproliferative disorders. WHO subtypes are defined in hierarchical groupings, with newly defined groups for small B-cell lymphomas with plasmacytic differentiation and for primary cutaneous T-cell lymphomas. We suggest approaches for applying the hierarchical classification in various epidemiologic settings, including strategies for dealing with multiple coexisting lymphoma subtypes in one patient, and cases with incomplete pathologic information. The pathology materials useful for state-of-the-art epidemiology studies are also discussed. We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Blood</journal-id><journal-id journal-id-type="hwp">bloodjournal</journal-id><journal-id journal-id-type="pmc">blood</journal-id><journal-id journal-id-type="publisher-id">Blood</journal-id><journal-title-group><journal-title>Blood</journal-title></journal-title-group><issn pub-type="ppub">0006-4971</issn><issn pub-type="epub">1528-0020</issn><publisher><publisher-name>American Society of Hematology</publisher-name><publisher-loc>Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20699439</article-id><article-id pub-id-type="pmc">2993636</article-id><article-id pub-id-type="publisher-id">2010/289561</article-id><article-id pub-id-type="doi">10.1182/blood-2010-06-289561</article-id><article-categories><subj-group subj-group-type="heading"><subject>Lymphoid Neoplasia</subject><subj-group><subject>e-<italic>Blood</italic></subject></subj-group></subj-group><series-title>Lymphoid Neoplasia</series-title></article-categories><title-group><article-title>InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Turner</surname><given-names>Jennifer J.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Morton</surname><given-names>Lindsay M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Linet</surname><given-names>Martha S.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Clarke</surname><given-names>Christina A.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kadin</surname><given-names>Marshall E.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Vajdic</surname><given-names>Claire M.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Monnereau</surname><given-names>Alain</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Maynadié</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Chiu</surname><given-names>Brian C.-H.</given-names></name><xref ref-type="aff" rid="aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Marcos-Gragera</surname><given-names>Rafael</given-names></name><xref ref-type="aff" rid="aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Costantini</surname><given-names>Adele Seniori</given-names></name><xref ref-type="aff" rid="aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Cerhan</surname><given-names>James R.</given-names></name><xref ref-type="aff" rid="aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Weisenburger</surname><given-names>Dennis D.</given-names></name><xref ref-type="aff" rid="aff12">12</xref></contrib><aff id="aff1"><label>1</label>Department of Histopathology, Douglass Hanly Moir Pathology, and the Australian School of Advanced Medicine, Macquarie University, Sydney, Australia;</aff><aff id="aff2"><label>2</label>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;</aff><aff id="aff3"><label>3</label>Cancer Prevention Institute of California, Fremont, CA;</aff><aff id="aff4"><label>4</label>Boston University School of Medicine, Department of Dermatology and Skin Surgery, Roger Williams Medical Center, Providence, RI;</aff><aff id="aff5"><label>5</label>Prince of Wales Clinical School and Lowy Cancer Research Center, University of New South Wales, Australia;</aff><aff id="aff6"><label>6</label>Hematological Malignancies Registry of Gironde, Bergonie Institute, Bordeaux, France, and UMRS-1018 Environmental Epidemiology of Cancer, Inserm, Paris-Sud University, Paris, France;</aff><aff id="aff7"><label>7</label>Hematological Malignancies Registry of Côte d'Or, University of Burgundy, Dijon, France;</aff><aff id="aff8"><label>8</label>Department of Health Studies, University of Chicago, Chicago, IL;</aff><aff id="aff9"><label>9</label>Epidemiology Unit, Cancer Registry of Girona, Oncology Planning, Department of Health, Institute of Biomedical Investigation, Girona, Spain;</aff><aff id="aff10"><label>10</label>Cancer Research and Prevention Institute Epidemiology, Florence, Italy;</aff><aff id="aff11"><label>11</label>Division of Epidemiology, College of Medicine, Mayo Clinic, Rochester, MN; and</aff><aff id="aff12"><label>12</label>Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE</aff></contrib-group><pub-date pub-type="ppub"><day>18</day><month>11</month><year>2010</year></pub-date><pub-date pub-type="epreprint"><day>10</day><month>8</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>11</month><year>2011</year></pub-date><pmc-comment> PMC Release delay is 12 months and 0 days and was based on the
<volume>116</volume><issue>20</issue><fpage>e90</fpage><lpage>e98</lpage><history><date date-type="received"><day>8</day><month>6</month><year>2010</year></date><date date-type="accepted"><day>1</day><month>8</month><year>2010</year></date></history><permissions><copyright-statement>© 2010 by The American Society of Hematology</copyright-statement></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zh804610000e90.pdf"></self-uri><abstract><p>After publication of the updated World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues in 2008, the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) now presents an update of the hierarchical classification of lymphoid neoplasms for epidemiologic research based on the 2001 WHO classification, which we published in 2007. The updated hierarchical classification incorporates all of the major and provisional entities in the 2008 WHO classification, including newly defined entities based on age, site, certain infections, and molecular characteristics, as well as borderline categories, early and “in situ” lesions, disorders with limited capacity for clinical progression, lesions without current International Classification of Diseases for Oncology, 3rd Edition codes, and immunodeficiency-associated lymphoproliferative disorders. WHO subtypes are defined in hierarchical groupings, with newly defined groups for small B-cell lymphomas with plasmacytic differentiation and for primary cutaneous T-cell lymphomas. We suggest approaches for applying the hierarchical classification in various epidemiologic settings, including strategies for dealing with multiple coexisting lymphoma subtypes in one patient, and cases with incomplete pathologic information. The pathology materials useful for state-of-the-art epidemiology studies are also discussed. We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications.</p></abstract><funding-group><award-group><funding-source id="CS100">National Institutes of Health</funding-source><award-id rid="CS100">R01 CA92153</award-id><award-id rid="CS100">R01 CA97274</award-id><award-id rid="CS100">P20RR018757</award-id></award-group></funding-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0017890 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0017890 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |